Oto Ozgur Akin, Demir Erol, Mirioglu Safak, Dirim Ahmet Burak, Ozluk Yasemin, Cebeci Egemen, Basturk Taner, Ucar Ali Riza, Soltanova Lala, Nuriyev Kanan, Kilicaslan Isin, Yazici Halil, Caliskan Yasar
Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
J Nephrol. 2021 Apr;34(2):581-587. doi: 10.1007/s40620-020-00915-w. Epub 2021 Jan 2.
We aimed to investigate the effects of glomerular C3 deposition on clinical, histopathological features, and outcomes of patients with primary membranous nephropathy (MN).
A total of 261 patients with biopsy-proven primary MN, who were on follow up for at least 6 months, were included in the study. The patients were grouped according to their C3 immunostaining in kidney biopsy samples at the time of diagnosis: Low intensity [LI; (C3 1 +)] and high intensity [HI; (C3 2 + or C3 3 +)]. The primary outcome was the development of kidney failure. Complete (CR) or partial remission (PR) was defined as secondary outcome.
Sixteen patients reached the primary outcome after a median follow-up of 33.8 months. Patients in the high intensity group (119 cases) had lower eGFR and higher proteinuria at admission and last follow-up compared to patients in the low intensity group (142 cases). Also, more patients in the high intensity group reached the primary outcome compared to patients in the low intensity group: twelve patients (10.1%) in the high intensity group and four patients (2.8%) in the low intensity group reached the primary outcome (p = 0.015). Kaplan-Meier analysis demonstrated that patients in the high intensity group had a higher risk for kidney failure (p = 0.02). In multivariate logistic regression analysis, high intensity C3 deposition and initial estimated glomerular filtration rate (eGFR) indepenently predicted primary outcome.
Extensive glomerular C3 deposition is a predictor of kidney failure in patients with MN.
我们旨在研究肾小球C3沉积对原发性膜性肾病(MN)患者的临床、组织病理学特征及预后的影响。
本研究纳入了261例经活检证实为原发性MN且至少随访6个月的患者。根据诊断时肾活检样本中的C3免疫染色情况将患者分组:低强度[LI;(C3 1+)]和高强度[HI;(C3 2+或C3 3+)]。主要结局为肾衰竭的发生。完全缓解(CR)或部分缓解(PR)被定义为次要结局。
中位随访33.8个月后,16例患者达到主要结局。与低强度组(142例)患者相比,高强度组(119例)患者入院时及末次随访时的估算肾小球滤过率(eGFR)更低,蛋白尿更高。此外,与低强度组患者相比,高强度组有更多患者达到主要结局:高强度组12例患者(10.1%)和低强度组4例患者(2.8%)达到主要结局(p = 0.015)。Kaplan-Meier分析表明,高强度组患者发生肾衰竭的风险更高(p = 0.02)。在多因素逻辑回归分析中,高强度C3沉积和初始估算肾小球滤过率(eGFR)独立预测主要结局。
广泛的肾小球C3沉积是MN患者肾衰竭的一个预测指标。